Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study.
Saved in:
| Title: | Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study. |
|---|---|
| Authors: | Corsini CA; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Campos GRF; Faculty of Medicine of São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil., Martins PFDS; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Filgueiras PS; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Lima AES; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Gomes SVC; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Curimbaba CAL; Instituto Butantan, São Paulo, São Paulo, Brazil., Lorencini DA; Instituto Butantan, São Paulo, São Paulo, Brazil., Morandi Junior E; Instituto Butantan, São Paulo, São Paulo, Brazil., da Silva VM; Instituto Butantan, São Paulo, São Paulo, Brazil., Cervi MC; Faculty of Medicine, University of São Paulo (USP), São Paulo, São Paulo, Brazil., Borges MC; Faculty of Medicine, University of São Paulo (USP), São Paulo, São Paulo, Brazil.; Serrana Clinical Research Center, Serrana, São Paulo, Brazil., de Lima PR; Serrana Clinical Research Center, Serrana, São Paulo, Brazil., do Nascimento JPR; Serrana Clinical Research Center, Serrana, São Paulo, Brazil., Correa PRL; Belo Horizonte Municipal Health Department (SMS), Belo Horizonte, Brazil., Castilho LDR; Cell Culture Engineering Laboratory (COPPE), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Rio de Janeiro, Brazil., de Oliveira JG; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Filho OAM; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Nogueira ML; Faculty of Medicine of São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil.; Hospital de Base, São José do Rio Preto, São Paulo, Brazil.; Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States., Grenfell RFQE; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.; Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.; Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia (UGA), Athens, GA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Jul 15; Vol. 16, pp. 1589733. Date of Electronic Publication: 2025 Jul 15 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1589733 |
